- Published at
- by marketscreener.com
positive
positive
Pixium Vision announces the 48-Month Trial Results in Severe Atrophic AMD
Pixium Vision announces the 48-Month Trial Results in Severe Atrophic AMD Study confirms subretinal prothesis feasible and well-tolerated with no reduction of natural peripheral vision, confirming...